Omega-3 compound shows promise in lab study to fight inflammation

NCT ID NCT05161702

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looks at whether a special form of omega-3 (monoglycerides) can help reduce inflammation in blood cells. Researchers will take blood from 200 healthy adults, treat the cells in a lab dish with an inflammatory agent, and then add the omega-3 compound to see if it lowers inflammation. The goal is to understand how omega-3s might work to resolve inflammation at the cellular level.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

omega-3 monoglycerides (MAG-SPM)

What this could lead to

If successful, this could point toward a new way to treat inflammation using omega-3s.

What could go wrong

This is a very early lab study using cells in a dish, not in people. It may not translate to real-world benefits.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RESOLUTION OF INFLAMMATION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • SCF Pharma

    RECRUITING

    Rimouski, Quebec, G0K 1P0, Canada

    Contact Phone: •••-•••-•••• Email: •••••@•••••